Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 22 studies | 26% ± 11% | |
adventitial cell | 5 studies | 51% ± 9% | |
myofibroblast cell | 4 studies | 26% ± 4% | |
mesothelial cell | 3 studies | 31% ± 9% |
Insufficient scRNA-seq data for expression of PODN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 14760.90 | 458 / 459 | 90% | 36.07 | 1003 / 1118 |
prostate | 95% | 8590.39 | 232 / 245 | 94% | 24.18 | 474 / 502 |
lung | 98% | 8318.04 | 568 / 578 | 85% | 21.86 | 984 / 1155 |
bladder | 100% | 12310.52 | 21 / 21 | 64% | 12.54 | 321 / 504 |
ovary | 100% | 21384.56 | 180 / 180 | 55% | 10.13 | 238 / 430 |
esophagus | 91% | 9128.30 | 1319 / 1445 | 60% | 13.40 | 109 / 183 |
intestine | 81% | 6710.30 | 787 / 966 | 69% | 14.87 | 362 / 527 |
stomach | 66% | 8034.45 | 236 / 359 | 76% | 23.93 | 217 / 286 |
uterus | 99% | 12143.78 | 169 / 170 | 40% | 8.43 | 185 / 459 |
thymus | 97% | 9512.93 | 635 / 653 | 29% | 3.92 | 176 / 605 |
pancreas | 20% | 576.73 | 66 / 328 | 93% | 41.69 | 165 / 178 |
skin | 65% | 3639.53 | 1173 / 1809 | 45% | 6.84 | 212 / 472 |
adipose | 100% | 19460.96 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 9791.66 | 1310 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 21.06 | 21 / 2642 | 79% | 15.14 | 556 / 705 |
heart | 78% | 5101.18 | 672 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 29% | 1013.05 | 75 / 258 | 27% | 2.89 | 62 / 230 |
tonsil | 0% | 0 | 0 / 0 | 44% | 4.48 | 20 / 45 |
kidney | 8% | 273.08 | 7 / 89 | 33% | 5.75 | 297 / 901 |
liver | 7% | 211.81 | 16 / 226 | 29% | 4.15 | 116 / 406 |
eye | 0% | 0 | 0 / 0 | 29% | 3.98 | 23 / 80 |
muscle | 23% | 773.75 | 181 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.99 | 4 / 29 |
spleen | 3% | 132.70 | 8 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 5.17 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0030021 | Molecular function | extracellular matrix structural constituent conferring compression resistance |
GO_0005518 | Molecular function | collagen binding |
Gene name | PODN |
Protein name | Podocan |
Synonyms | UNQ293/PRO332 SLRR5A |
Description | FUNCTION: Negatively regulates cell proliferation and cell migration. . |
Accessions | ENST00000673956.1 ENST00000371500.8 [Q7Z5L7-2] ENST00000395871.7 [Q7Z5L7-3] ENST00000618387.1 [Q7Z5L7-2] A0A669KB13 ENST00000312553.10 [Q7Z5L7-1] ENST00000673702.1 A0A669KBI2 Q7Z5L7 |